BJU Int

1. UEKI H, Uemura M, Chinzei K, Takahashi K, et al
   Developing an artificial intelligence model for phase recognition in robot-assisted radical prostatectomy.
   BJU Int. 2025;136:891-901.
   

   >> Share

   
   
2. HANDA N, Shore ND, Cooperberg MR, Davicioni E, et al
   Transcriptome profiling of prostatic tumours from ENACT trial patients with or without enzalutamide.
   BJU Int. 2025;136:920-929.
   

   >> Share

   
   
3. CANNOLETTA D, Stabile A, Quarta L, Barletta F, et al
   Utility of MRI perilesional biopsy in prostate cancer: impact of the Prostate Imaging-Reporting and Data System and biopsy history.
   BJU Int. 2025 Oct 13. doi: 10.1111/bju.70027.
   

   >> Share

   
   

   
   BMC Cancer

4. YEBOAH KO, Atawuchugi P, Baah FK, Petershie BE, et al
   The impact of zinc and testosterone co-treatment on tumourigenesis in prostate cancer: a novel model.
   BMC Cancer. 2025;25:1552.
   

   >> Share

   
   

   
   Br J Cancer

5. ZUCKER K, McInerney C, Glaser A, Baxter P, et al
   Why NHS hospital co-morbidity research may be wrong: how clinical coding fails to identify the impact of diabetes mellitus on cancer survival.
   Br J Cancer. 2025;133:1137-1144.
   

   >> Share

   
   

   
   Br J Radiol

6. KURU OZ D, Yilmazer Zorlu SN, Eskalen Z, Haliloglu N, et al
   Reevaluating prostate imaging-reporting and data system 3 lesions upgraded to 4: the emergence of a new subgroup?
   Br J Radiol. 2025;98:1683-1689.
   

   >> Share

   
   
7. COOPER S, Chick J, Casey F, Alexander S, et al
   Simulation-free radiotherapy on the MR-linac in prostate cancer.
   Br J Radiol. 2025;98:1591-1595.
   

   >> Share

   
   

   
   Cancer

8. 
   Erratum to "Consensus-built recommendations to improve prostate cancer outcomes: A summary of the American Cancer Society Prostate Cancer Collaborative".
   Cancer. 2025;131:e70105.
   

   >> Share

   
   

   
   Clin Cancer Res

9. BOUZAKI A, Vasquez Osorio E, Kerns S, van Herk M, et al
   Integration of dose surface maps and genetic data identifies the lower posterior rectum as a key region for toxicity after prostate cancer radiotherapy.
   Clin Cancer Res. 2025 Oct 13. doi: 10.1158/1078-0432.CCR-25-2102.
   

   >> Share

   
   
10. BRIGHI N, Wetterskog D, Vainauskas O, Orlando F, et al
    Liquid biopsy identifies taxane resistance and clonal selection in castration-resistant prostate cancer.
    Clin Cancer Res. 2025 Oct 13. doi: 10.1158/1078-0432.CCR-25-2121.
    

    >> Share

    
    

    
    Eur Urol

11. RIAZ IB, Cheng L, Montironi R
    Histopathology-only Artificial Intelligence for Prostate Cancer: Towards Accessible Risk Stratification.
    Eur Urol. 2025 Oct 10:S0302-2838(25)04722-0. doi: 10.1016/j.eururo.2025.09.4164.
    

    >> Share

    
    

    
    Int J Cancer

12. VLAMING M, Bleiker EMA, Schijven G, Kiemeney LALM, et al
    Experiences of metastatic prostate cancer patients with a mainstream genetic testing pathway.
    Int J Cancer. 2025 Oct 13. doi: 10.1002/ijc.70194.
    

    >> Share

    
    

    
    Int J Radiat Oncol Biol Phys

13. FITZPATRICK KJ, Mikell JK, Roseland ME, Niedbala J, et al
    (177)Lu-PSMA-617 Single-Photon Emission Computed Tomography/Computed Tomography Dosimetry and Radiobiological Models Demonstrate Decreasing Tumor-to-Kidney Dose Ratio With Successive Cycles.
    Int J Radiat Oncol Biol Phys. 2025;123:937-946.
    

    >> Share

    
    
14. DONG A, Sun X, Chen L, Tsai Y, et al
    KDM3B Regulates Postradiation Fibrotic Responses in Prostate Stroma via N(6)-methyladenosine Modification of LOX.
    Int J Radiat Oncol Biol Phys. 2025;123:1116-1131.
    

    >> Share

    
    
15. LUKKA HR, Pugh SL, Shipley WU, Major PP, et al
    Long-Term Results of NRG/RTOG 9601, a Randomized Trial of Radiation With or Without Antiandrogens in Patients Receiving Salvage Prostate Bed Radiation Therapy Postprostatectomy.
    Int J Radiat Oncol Biol Phys. 2025;123:990-999.
    

    >> Share

    
    
16. SAYAN M, Miric G, Wallner KE, King MT, et al
    Beyond the Beam: Redefining Survivorship in Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2025;123:1000-1003.
    

    >> Share

    
    
17. NEILSEN BK, Huang RR, Valle LF, Proudfoot JA, et al
    Genomic and Transcriptomic Profiling of Radiation-Resistant, Locally Recurrent Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2025 Sep 29:S0360-3016(25)06298.
    

    >> Share

    
    

    
    Int J Urol

18. KAWAHARA T
    Re: Androgen Receptor Signaling Inhibitors in Non-Metastatic Castration-Resistant Prostate Cancer in Japan: The ARASHI Study.
    Int J Urol. 2025 Oct 15. doi: 10.1111/iju.70259.
    

    >> Share

    
    
19. ALANBUKI A
    Editorial Comment: Prostate-Specific Antigen Dynamics and Bone Predominance as Predictors of Efficacy in Radium-223 Treatment for Castration-Resistant Prostate Cancer.
    Int J Urol. 2025 Oct 15. doi: 10.1111/iju.70264.
    

    >> Share

    
    
20. YAJIMA S, Yoshida S, Fukushima H, Hirakawa A, et al
    Bayesian Reanalysis of Enzalutamide Plus Androgen Deprivation Therapy in Japanese Patients With Metastatic Hormone-Sensitive Prostate Cancer: A Methodological Complement to Frequentist Analysis From the ARCHES Trial.
    Int J Urol. 2025 Oct 12. doi: 10.1111/iju.70256.
    

    >> Share

    
    

    
    J Clin Oncol

21. LIN JK, Niu J, Giordano SH, Li P, et al
    Racial and Ethnic Disparities Along the Treatment Cascade Among Medicare Fee-for-Service Beneficiaries With Metastatic Breast, Colorectal, Lung, and Prostate Cancers.
    J Clin Oncol. 2025;43:3254-3265.
    

    >> Share

    
    

    
    J Nucl Med

22. MILLER SR, Chung DH, Gonzalez RT, Jackson WC, et al
    Impact of PSMA PET Staging on Initial Treatment in Newly Diagnosed Prostate Cancer.
    J Nucl Med. 2025 Oct 16:jnumed.125.270825. doi: 10.2967/jnumed.125.270825.
    

    >> Share

    
    

    
    Magn Reson Imaging

23. CHEN R, Hu G, Zhou B, Gan H, et al
    Combination of clinicopathological and MRI based radiomics features in predicting homologous recombination repair genes mutations in prostate cancer.
    Magn Reson Imaging. 2025;124:110534.
    

    >> Share

    
    

    
    Nat Rev Urol

24. RATNER D, Vassy JL
    Clinical translation of polygenic scores for prostate cancer screening.
    Nat Rev Urol. 2025 Oct 13. doi: 10.1038/s41585-025-01095.
    

    >> Share

    
    

    
    PLoS One

25. LI Y, Gillanders D, Finucane A
    Experience of uncertainty in prostate cancer: A qualitative study.
    PLoS One. 2025;20:e0334180.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

26. XIE J, Shen K, Liang W, Kuang Z, et al
    Protein disulfide isomerases regulate androgen receptor stability and promote prostate cancer cell growth and survival.
    Proc Natl Acad Sci U S A. 2025;122:e2509222122.
    

    >> Share

    
    

    
    Urol Int

27. RISCH J, Hugelmann K, Buck L, von Knobloch HC, et al
    Readability of Prostate Cancer Patient Education Materials: A Comprehensive Assessment Using Readability Metrics.
    Urol Int. 2025 Oct 9:1-15. doi: 10.1159/000548884.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share